MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-28.6%
5Y CAGR+0.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-28.6%/yr
Annual compound
5Y CAGR
+0.9%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.23M | +7.6% |
| 2024 | $10.43M | -54.1% |
| 2023 | $22.72M | -26.3% |
| 2022 | $30.83M | +66.4% |
| 2021 | $18.53M | +72.5% |
| 2020 | $10.74M | -53.2% |
| 2019 | $22.97M | - |